Cargando…
A missense mutation (Q279R) in the Fumarylacetoacetate Hydrolase gene, responsible for hereditary tyrosinemia, acts as a splicing mutation
BACKGROUND: Tyrosinemia type I, the most severe disease of the tyrosine catabolic pathway is caused by a deficiency in fumarylacetoacetate hydrolase (FAH). A patient showing few of the symptoms associated with the disease, was found to be a compound heterozygote for a splice mutation, IVS6-1g->t,...
Autores principales: | Dreumont, Natacha, Poudrier, Jacques A, Bergeron, Anne, Levy, Harvey L, Baklouti, Faouzi, Tanguay, Robert M |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC35353/ https://www.ncbi.nlm.nih.gov/pubmed/11476670 http://dx.doi.org/10.1186/1471-2156-2-9 |
Ejemplares similares
-
Fumarylacetoacetate Hydrolase Knock-out Rabbit Model for Hereditary Tyrosinemia Type 1
por: Li, Li, et al.
Publicado: (2017) -
Hereditary tyrosinemia type I–associated mutations in fumarylacetoacetate hydrolase reduce the enzyme stability and increase its aggregation rate
por: Macias, Iratxe, et al.
Publicado: (2019) -
A minor alternative transcript of the fumarylacetoacetate hydrolase gene produces a protein despite being likely subjected to nonsense-mediated mRNA decay
por: Dreumont, Natacha, et al.
Publicado: (2005) -
Identification and functional characterization of a novel homozygous intronic variant in the fumarylacetoacetate hydrolase gene in a Chinese patient with tyrosinemia type 1
por: Chen, Jiao, et al.
Publicado: (2022) -
Clinical and genetic characteristics of two patients with tyrosinemia type 1 in Slovenia – A novel fumarylacetoacetate hydrolase (FAH) intronic disease-causing variant
por: Sikonja, Jaka, et al.
Publicado: (2021)